56 related articles for article (PubMed ID: 16218027)
1. Increased plasma TGF-beta 1 level in patient with salivary gland carcinoma after renal transplantation.
Boratyńska M; Watorek E; Falkiewicz K; Banasik M
Ann Transplant; 2005; 10(2):16-9. PubMed ID: 16218027
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma TGF-beta1 in renal diseases: cause or consequence?
Junker U; Haufe CC; Nuske K; Rebstock K; Steiner T; Wunderlich H; Junker K; Reinhold D
Cytokine; 2000 Jul; 12(7):1084-91. PubMed ID: 10880255
[TBL] [Abstract][Full Text] [Related]
3. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta 1 in renal allograft recipients.
Coupes BM; Newstead CG; Short CD; Brenchley PE
Transplantation; 1994 Jun; 57(12):1727-31. PubMed ID: 8016876
[TBL] [Abstract][Full Text] [Related]
6. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
[TBL] [Abstract][Full Text] [Related]
7. Mucoepidermoid parotid carcinoma after renal transplantation.
Anirban G; Singh BA; Kumar GP; Raman A; Ashru B
Transpl Int; 2009 Dec; 22(12):1195-7. PubMed ID: 19619172
[No Abstract] [Full Text] [Related]
8. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
9. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma.
Dong L; Ge XY; Wang YX; Yang LQ; Li SL; Yu GY; Gao Y; Fu J
Oral Oncol; 2013 Nov; 49(11):1051-8. PubMed ID: 23962790
[TBL] [Abstract][Full Text] [Related]
11. Urine excretion of transforming growth factor-beta1 in chronic allograft nephropathy.
Boratyńska M
Ann Transplant; 1999; 4(2):23-8. PubMed ID: 10850587
[TBL] [Abstract][Full Text] [Related]
12. [Association between TGF-Beta1 in allograft and chronic allograft nephropathy].
Wang PX; Fan MQ; Gong GZ; Xu HY; Huang CB; Zhang GT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):112-4, 122. PubMed ID: 16468656
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 impairs homocysteine metabolism in human renal cells: possible implications for transplantation.
Sengoelge G; Kletzmayr J; Papagiannopoulos M; Bohle B; Hörl WH; Födinger M; Sunder-Plassmann G
Transpl Int; 2003 Dec; 16(12):843-8. PubMed ID: 12897987
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of basic fibroblast growth factor and transforming growth factor-beta 1 in mucoepidermoid carcinoma with different malignant degree].
Cao YT; Zhao D; Yang S; Wang XY; Gao QH; Xuan M; Cao JF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):881-4. PubMed ID: 19950605
[TBL] [Abstract][Full Text] [Related]
16. Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells.
Moodley R; Snyman C; Odhav B; Bhoola KD
Biol Chem; 2005 Apr; 386(4):375-82. PubMed ID: 15899700
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
18. Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma.
Okumoto K; Hattori E; Tamura K; Kiso S; Watanabe H; Saito K; Saito T; Togashi H; Kawata S
Liver Int; 2004 Feb; 24(1):21-8. PubMed ID: 15101997
[TBL] [Abstract][Full Text] [Related]
19. [Expression of TGF beta 1 and TGF beta RI proteins in tissues of salivary adenoid cystic carcinoma].
Guo F; Jian XC; Cheng RX
Hunan Yi Ke Da Xue Xue Bao; 2002 Jun; 27(3):229-32. PubMed ID: 12575299
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.
Hasegawa Y; Takanashi S; Kanehira Y; Tsushima T; Imai T; Okumura K
Cancer; 2001 Mar; 91(5):964-71. PubMed ID: 11251948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
